BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 20483762)

  • 1. Blockade of CCL1 inhibits T regulatory cell suppressive function enhancing tumor immunity without affecting T effector responses.
    Hoelzinger DB; Smith SE; Mirza N; Dominguez AL; Manrique SZ; Lustgarten J
    J Immunol; 2010 Jun; 184(12):6833-42. PubMed ID: 20483762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signals through 4-1BB inhibit T regulatory cells by blocking IL-9 production enhancing antitumor responses.
    Smith SE; Hoelzinger DB; Dominguez AL; Van Snick J; Lustgarten J
    Cancer Immunol Immunother; 2011 Dec; 60(12):1775-87. PubMed ID: 21789593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suberanilohydroxamic acid (SAHA), a HDAC inhibitor, suppresses the effect of Treg cells by targeting the c-Myc/CCL1 pathway in glioma stem cells and improves PD-L1 blockade therapy.
    Sun T; Liu B; Cai L; Zhou Y; Yang W; Li Y
    J Neurooncol; 2024 Jul; 168(3):457-471. PubMed ID: 38652401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratumoral regulatory T cells with higher prevalence and more suppressive activity in hepatocellular carcinoma patients.
    Wu H; Chen P; Liao R; Li YW; Yi Y; Wang JX; Cai XY; He HW; Jin JJ; Cheng YF; Fan J; Sun J; Qiu SJ
    J Gastroenterol Hepatol; 2013 Sep; 28(9):1555-64. PubMed ID: 23517245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fc-Optimized Anti-CCR8 Antibody Depletes Regulatory T Cells in Human Tumor Models.
    Campbell JR; McDonald BR; Mesko PB; Siemers NO; Singh PB; Selby M; Sproul TW; Korman AJ; Vlach LM; Houser J; Sambanthamoorthy S; Lu K; Hatcher SV; Lohre J; Jain R; Lan RY
    Cancer Res; 2021 Jun; 81(11):2983-2994. PubMed ID: 33757978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic targeting of CpG-ODN to the tumor microenvironment with anti-neu-CpG hybrid molecule and T regulatory cell depletion induces memory responses in BALB-neuT tolerant mice.
    Sharma S; Dominguez AL; Manrique SZ; Cavallo F; Sakaguchi S; Lustgarten J
    Cancer Res; 2008 Sep; 68(18):7530-40. PubMed ID: 18794141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of tumor necrosis factor-α induced protein 8 like-2 contributes to the immunosuppressive property of CD4(+)CD25(+) regulatory T cells in mice.
    Luan YY; Yao YM; Zhang L; Dong N; Zhang QH; Yu Y; Sheng ZY
    Mol Immunol; 2011 Oct; 49(1-2):219-26. PubMed ID: 21963221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting CCR8 Induces Protective Antitumor Immunity and Enhances Vaccine-Induced Responses in Colon Cancer.
    Villarreal DO; L'Huillier A; Armington S; Mottershead C; Filippova EV; Coder BD; Petit RG; Princiotta MF
    Cancer Res; 2018 Sep; 78(18):5340-5348. PubMed ID: 30026324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic Regulation of Tregs in Cancer: Opportunities for Immunotherapy.
    Wang H; Franco F; Ho PC
    Trends Cancer; 2017 Aug; 3(8):583-592. PubMed ID: 28780935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Notch-1 Inhibition Promotes Immune Regulation in Transplantation Via Regulatory T Cell-Dependent Mechanisms.
    Magee CN; Murakami N; Borges TJ; Shimizu T; Safa K; Ohori S; Cai S; Uffing A; Azzi J; Elyaman W; Charbonnier LM; Liu K; Toprak D; Visner G; Chatila TA; Siebel CW; Najafian N; Riella LV
    Circulation; 2019 Sep; 140(10):846-863. PubMed ID: 31266349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting MARCO and IL37R on Immunosuppressive Macrophages in Lung Cancer Blocks Regulatory T Cells and Supports Cytotoxic Lymphocyte Function.
    La Fleur L; Botling J; He F; Pelicano C; Zhou C; He C; Palano G; Mezheyeuski A; Micke P; Ravetch JV; Karlsson MCI; Sarhan D
    Cancer Res; 2021 Feb; 81(4):956-967. PubMed ID: 33293426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TNF activates a NF-kappaB-regulated cellular program in human CD45RA- regulatory T cells that modulates their suppressive function.
    Nagar M; Jacob-Hirsch J; Vernitsky H; Berkun Y; Ben-Horin S; Amariglio N; Bank I; Kloog Y; Rechavi G; Goldstein I
    J Immunol; 2010 Apr; 184(7):3570-81. PubMed ID: 20181891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutting edge: expression of TNFR2 defines a maximally suppressive subset of mouse CD4+CD25+FoxP3+ T regulatory cells: applicability to tumor-infiltrating T regulatory cells.
    Chen X; Subleski JJ; Kopf H; Howard OM; Männel DN; Oppenheim JJ
    J Immunol; 2008 May; 180(10):6467-71. PubMed ID: 18453563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4 blockade directly inhibits mouse and human CD4(+) T cell functions independent of Foxp3(+) Tregs.
    Mayer CT; Huntenburg J; Nandan A; Schmitt E; Czeloth N; Sparwasser T
    J Autoimmun; 2013 Dec; 47():73-82. PubMed ID: 24055067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effector/memory but not naive regulatory T cells are responsible for the loss of concomitant tumor immunity.
    Lin YC; Chang LY; Huang CT; Peng HM; Dutta A; Chen TC; Yeh CT; Lin CY
    J Immunol; 2009 May; 182(10):6095-104. PubMed ID: 19414761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-2 immunotoxin therapy modulates tumor-associated regulatory T cells and leads to lasting immune-mediated rejection of breast cancers in neu-transgenic mice.
    Knutson KL; Dang Y; Lu H; Lukas J; Almand B; Gad E; Azeke E; Disis ML
    J Immunol; 2006 Jul; 177(1):84-91. PubMed ID: 16785502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of regulatory T cells in cancer immunity.
    Takeuchi Y; Nishikawa H
    Int Immunol; 2016 Aug; 28(8):401-9. PubMed ID: 27160722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Instability of Helios-deficient Tregs is associated with conversion to a T-effector phenotype and enhanced antitumor immunity.
    Nakagawa H; Sido JM; Reyes EE; Kiers V; Cantor H; Kim HJ
    Proc Natl Acad Sci U S A; 2016 May; 113(22):6248-53. PubMed ID: 27185917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-γ, CXCL9 and CXCL10.
    Bergamaschi C; Pandit H; Nagy BA; Stellas D; Jensen SM; Bear J; Cam M; Valentin A; Fox BA; Felber BK; Pavlakis GN
    J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32461349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FoxP3
    Saleh R; Elkord E
    Cancer Lett; 2020 Oct; 490():174-185. PubMed ID: 32721551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.